Vision & Mission

We are Word Consulting Group, Ltd. Our vision is to be the "company of choice" in developing quality medical content and education for our global medical communications partners.

Our mission is to analyze emerging scientific information and translate it into effective medical education. We partner with key stakeholders to disseminate medical education programs to improve people's lives.

Our success is a reflection of how closely we adhere to our core values of excellence and continuous improvement, open communication, respect for individual talents and values, personal accountability, integrity, and honesty.

WCG works with the global medical communications community in transforming information to medical education.

Management Team

Jose Conrado Poblete, PhD

Dr. Poblete is the Founder and President of Word Consulting Group, Ltd (Hongkong). Prior to establishing WCG, he spent eight years with Phase Five Communications, Inc., a division of Grey Healthcare Group in New York, New York, USA, where he was Vice-President/Group Scientific Supervisor prior to his leaving for Asia to realize his dream of creating a new kind of medical communications company. He has extensive experience in strategic planning and tactical execution of medical education programs. As a manager, he led several business segments, trained biomedical writer teams, and implemented various leadership team initiatives for increased efficiency and profitability. As a strategic and tactical planner, Dr. Poblete developed scientific communication plans to support both US and Global product life cycle management programs, and collaborated with Brand-Medical-Legal-Regulatory review committees to ensure tactical plan compliance with ACCME, PhRMA and/or OIG guidelines.

Dr. Poblete's experience also includes being a Visiting Scientist for Max Planck Institute for Experimental Medicine in Germany and in the Department of Psychology of the Memorial University of Newfoundland in Canada. He also served as an Adjunct Faculty member at New York University for several years, and he has authored numerous scientific publications.

Dr. Poblete received his Doctor of Philosophy degree (with distinction) in Biology from New York University where he specialized in Neuroscience. His thesis describes the role of energy metabolism on the 3,4-methylenedioxymethamphetamine (MDMA/Ecstasy)-induced serotonin nerve degeneration. He has published several articles on this topic, as well as on the effects of other drugs of abuse in serotonin signaling mechanisms. He also earned a Master of Science degree in Biology specializing in Neurobiology and Physiology at NYU. He is a graduate of Lehigh University, College of Engineering and Applied Science in Bethlehem, Pennsylvania, USA, with a Bachelor of Science degree in Biochemistry.